Biodefense Threat Analysis & Communications Center
Pandemic Influenza: Contingency
Planning Discussion
Contact: Stephen M. Apatow, Director of
Research and Development, Humanitarian University
Consortium GraduateStudies
Center for Medicine,
Veterinary
Medicine and Law.
Email:
s.m.apatow@pathobiologics.org
The following topic has been opened for
discussion with the IVPHC Working Group.
In The Spotlight
Related News
ProMED: 24 January 2007, Archive 20070124.0323
PNAS
| December 19, 2006 | vol. 103 | no. 51 | 19368-19373
Predicting
the global spread of H5N1 avian influenza A: *Consortium for Conservation
Medicine, New York, NY 10001; Royal Society for the Protection of Birds, Sandy,
Bedfordshire SG19 2DL, United Kingdom; and National Museum of Natural History,
and Smithsonian Migratory Bird Center, National Zoological Park, Smithsonian
Institution, Washington, DC 20008
The spread of highly pathogenic H5N1 avian influenza into Asia, Europe,
and Africa has resulted in enormous impacts on the poultry industry and presents
an important threat to human health. The pathways by which the virus has
and will spread between countries
have been debated extensively, but have yet to be analyzed comprehensively
and quantitatively. We integrated data on phylogenetic relationships of
virus isolates, migratory bird movements, and trade in poultry and wild
birds to determine the
pathway for 52 individual introduction events into countries and predict
future spread. We show that 9 of 21 of H5N1 introductions to countries in
Asia were most likely through poultry, and 3 of 21 were most likely through
migrating birds. In contrast, spread to most
(20/23) countries in Europe was most likely through migratory birds. Spread
in Africa was likely partly by poultry (2/8 introductions) and partly by
migrating birds (3/8). Our analyses predict that H5N1 is more likely to be
introduced into the Western Hemisphere through infected poultry and into
the mainland United States by subsequent movement of migrating birds from
neighboring countries, rather than from eastern Siberia. These results highlight
the potential synergism between trade and wild animal movement in the emergence
and pandemic spread of pathogens and demonstrate the value of predictive
models for disease control. |
- Avian influenza, human (140): atypical infections:
CDC, NEJM references indicate that atypical infections (encephalitis, diarrheal,
gastrointestinal illness) are a serious concern associated with outbreaks
of avian influenza A subtype H5N1 worldwide. -- ProMED, 5 September 2006.
- Co-Infection Influenza A - Methicillin Resistant Staphylococcus
Aureus (MRSA): MRSA, endemic in many hospitals, one of the leading causes
of nosocomial pneumonia and surgical site infection and the second leading
cause of nosocomial blood stream infections. Prevention Methods for Airborne
transmission of staphylococcol pneumonia.
- Influenza A/MRSA/Toxic Shock Syndrome (TSS): Discussion
papers, related information.
- CBN Report: Antibiotics to Treat Pneumonia: An Overlooked
Essential Element of Pandemic Preparedness: Clinicians Biosecurity Network,
Center for Biosecurity, 1 September 2006.
-
-
- International Health Regulations (Revisions Approved):
ProMED 22 May 2005. See
also: Proposed new
International Health Regulations, Agreement must be reached
to protect the global village from pandemic influenza,
BMJ 2005;330:321-322 (12 February),
doi:10.1136/bmj.330.7487.321.
-
Pandemic Flu: We Are Not Prepared: "Pandemic flu is
an enemy that we know will return. Indeed, of the 12 disaster scenarios recently
assessed by the US Department of Homeland Security, it is the most likely
and
perhaps the most deadly. Our
surveillance and countermeasures abroad are inadequate, and current response
plans won't do much to slow a pandemic once it is under way. The United
States, and the world, must meet this enemy with the seriousness, the
investment, and the urgency that it demands. -- Medscape General Medicine,
15 April 2005.
-
- Halvorsen: contingency
planning for pandemic influenza:
Discussion on Vaccine Development, 27 October
2004
Recent Publications
- Low Dose Interferon, Immune Modulation and Emergency Influenza
Prophylaxis: , Joseph M. Cummins, DVM, PhD, Chad G.
Thompson, BA, December 2004. See also "Systemic effects of interferons after oral administration
in animals and humans," AJVR, Vol 66, No. 1, January 2005.
Pandemic Influenza:
International Contingency Planning
In
December 2003, Highly Pathogenic Avian Influenza
(HPAI) was confirmed about 80 kilometres south-east of the
capital, Seoul (December 2003), it was noted that if the outbreak moved beyond
the borders of Korea to countries in the East Asian-Australasian Flyway via
migratory bird patterns, could we be looking at a widespread international
multi-country outbreak (such as West Nile
Virus throughout North America).
The East Asian-Australasian
Flyway stretches from within the Arctic Circle in Siberia and
western Alaska, through North and South East Asia to Australia
and Aotearoa/New Zealand. It covers twenty countries including
Russia, Japan, China, Taiwan, Korea, Malaysia, Thailand, Vietnam,
Philippines, Indonesia, Mongolia, Alaska, Cambodia, Myanmar, Bangladesh,
East Timor, Brunei, Singapore and Papua New Guinea, as well as Australia
and Aotearoa/New Zealand.
On 25 October 2004
(Bird Flu Found in Migrant Birds
in Siberia), MosNews reported:
"The bird flu virus has been discovered
in migrant birds living in Novosibirsk region. Ducks and geese
are thought to have brought the virus from South East Asia, the
head of a local zoogenous infections laboratory, Alexander Shestopalov,
was quoted by Interfax news agency as saying."
As the World Health
Organization redefined international law during the SARS outbreak,
we were fortunate that 90% of patients recovered without hospitalization
(SARS coronavirus: a new challenge for prevention and therapy), while from a biodefense standpoint the viral
strain presented a new challenge:
"The genes of SARS-CoV were compared with the corresponding
genes of known coronaviruses of humans, pigs, cattle, dogs, cats,
mice, rats, chickens, and turkeys. Each gene of SARS-CoV has only
70% or less identity with the corresponding gene of the known coronaviruses.
Thus, SARS-CoV is only dis-tantly related to the known coronaviruses
of humans and animals. Phylogenetic analysis suggests that SARS-CoV
does not fit within any of the three groups that contain all other
known coronaviruses."
Today, a global population
of approximately
6.4 billion, must be considered in contingency
plans for containment and control of a pandemic influenza outbreak.
Papers:
Related:
- Avian Influenza: Dave Halvorson,
College Of
Veterinary Medicine, University of Minnesota.
- Influenza: Biodefense and Epidemiological Tracking,
Humanitarian Resource Institute.
- West Nile Virus: Biodefense and Epidemiological Tracking,
Humanitarian Resource Institute.
|